Treatment during a developmental window prevents NF1-associated optic pathway gliomas by targeting Erk-dependent migrating glial progenitors. - Physician's Weekly

About The Expert

Emmanuelle S Jecrois

Gilbert Family Neurofibromatosis Institute, Children’s National Hospital, Washington, DC 20010, USA; Center for Cancer and Immunology Research, Children’s National Hospital, Washington, DC 20010, USA; Center for Neuroscience Research, Children’s National Hospital, Washington, DC 20010, USA; Neuroscience Graduate Program, University of Michigan Medical School, Ann Arbor, MI 48109, USA.

Wang Zheng

Gilbert Family Neurofibromatosis Institute, Children’s National Hospital, Washington, DC 20010, USA; Center for Cancer and Immunology Research, Children’s National Hospital, Washington, DC 20010, USA; Center for Neuroscience Research, Children’s National Hospital, Washington, DC 20010, USA.

Miriam Bornhorst

Gilbert Family Neurofibromatosis Institute, Children’s National Hospital, Washington, DC 20010, USA; Center for Cancer and Immunology Research, Children’s National Hospital, Washington, DC 20010, USA; Center for Neuroscience Research, Children’s National Hospital, Washington, DC 20010, USA; Center for Genetic Medicine Research, Children’s National Hospital, Washington, DC 20010, USA.

Yinghua Li

Gilbert Family Neurofibromatosis Institute, Children’s National Hospital, Washington, DC 20010, USA; Center for Cancer and Immunology Research, Children’s National Hospital, Washington, DC 20010, USA; Center for Neuroscience Research, Children’s National Hospital, Washington, DC 20010, USA.

Daniel M Treisman

Gilbert Family Neurofibromatosis Institute, Children’s National Hospital, Washington, DC 20010, USA; Center for Cancer and Immunology Research, Children’s National Hospital, Washington, DC 20010, USA; Center for Neuroscience Research, Children’s National Hospital, Washington, DC 20010, USA.

Daphine Muguyo

Gilbert Family Neurofibromatosis Institute, Children’s National Hospital, Washington, DC 20010, USA; Center for Cancer and Immunology Research, Children’s National Hospital, Washington, DC 20010, USA; Center for Neuroscience Research, Children’s National Hospital, Washington, DC 20010, USA.

Sharon Huynh

Gilbert Family Neurofibromatosis Institute, Children’s National Hospital, Washington, DC 20010, USA; Center for Cancer and Immunology Research, Children’s National Hospital, Washington, DC 20010, USA; Center for Neuroscience Research, Children’s National Hospital, Washington, DC 20010, USA.

Shayne F Andrew

Gilbert Family Neurofibromatosis Institute, Children’s National Hospital, Washington, DC 20010, USA; Center for Cancer and Immunology Research, Children’s National Hospital, Washington, DC 20010, USA; Center for Neuroscience Research, Children’s National Hospital, Washington, DC 20010, USA.

Yuan Wang

Gilbert Family Neurofibromatosis Institute, Children’s National Hospital, Washington, DC 20010, USA; Center for Cancer and Immunology Research, Children’s National Hospital, Washington, DC 20010, USA; Center for Neuroscience Research, Children’s National Hospital, Washington, DC 20010, USA.

Jingwen Jiang

Gilbert Family Neurofibromatosis Institute, Children’s National Hospital, Washington, DC 20010, USA; Center for Cancer and Immunology Research, Children’s National Hospital, Washington, DC 20010, USA; Center for Neuroscience Research, Children’s National Hospital, Washington, DC 20010, USA.

Brianna R Pierce

Gilbert Family Neurofibromatosis Institute, Children’s National Hospital, Washington, DC 20010, USA; Center for Cancer and Immunology Research, Children’s National Hospital, Washington, DC 20010, USA; Center for Neuroscience Research, Children’s National Hospital, Washington, DC 20010, USA.

Hongmei Mao

Gilbert Family Neurofibromatosis Institute, Children’s National Hospital, Washington, DC 20010, USA; Center for Cancer and Immunology Research, Children’s National Hospital, Washington, DC 20010, USA; Center for Neuroscience Research, Children’s National Hospital, Washington, DC 20010, USA.

Matthew K Krause

Gilbert Family Neurofibromatosis Institute, Children’s National Hospital, Washington, DC 20010, USA; Center for Cancer and Immunology Research, Children’s National Hospital, Washington, DC 20010, USA; Center for Neuroscience Research, Children’s National Hospital, Washington, DC 20010, USA.

Austin Friend

Gilbert Family Neurofibromatosis Institute, Children’s National Hospital, Washington, DC 20010, USA; Center for Cancer and Immunology Research, Children’s National Hospital, Washington, DC 20010, USA; Center for Neuroscience Research, Children’s National Hospital, Washington, DC 20010, USA.

Francisco Nadal-Nicolas

Retinal Neurophysiology Section, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Steven F Stasheff

Gilbert Family Neurofibromatosis Institute, Children’s National Hospital, Washington, DC 20010, USA; Retinal Neurophysiology Section, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Wei Li

Retinal Neurophysiology Section, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Hui Zong

Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA 22908, USA.

Roger J Packer

Gilbert Family Neurofibromatosis Institute, Children’s National Hospital, Washington, DC 20010, USA.

Yuan Zhu

Gilbert Family Neurofibromatosis Institute, Children’s National Hospital, Washington, DC 20010, USA; Center for Cancer and Immunology Research, Children’s National Hospital, Washington, DC 20010, USA; Center for Neuroscience Research, Children’s National Hospital, Washington, DC 20010, USA; Neuroscience Graduate Program, University of Michigan Medical School, Ann Arbor, MI 48109, USA; GW Cancer Center, George Washington University, Washington, DC 20052. Electronic address: yzhu@childrensnational.org.

References

PubMed